December 11, 2024 | ESG, Sustainability
Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering commitment to sustainability and advanced ESG practices.

Following the assessment of the 2024 EcoVadis submission, Cuttsy+Cuttsy is excited to announce they have been awarded a Gold Medal on their sustainability scorecard. This places the agency among the top 5% of companies assessed by EcoVadis in the past 12 months.
Not only this, but Cuttsy+Cuttsy’s high score placed them in the 97th percentile of all companies assessed in 2024, making them just shy of a platinum rating (the top possible rating within the EcoVadis scoring system).
EcoVadis, a globally trusted provider of business sustainability ratings with a network of over 130,000 rated companies, works with organisations of all sizes to measure sustainability performance. The platform offers detailed insights on environmental, social and governance (ESG) risk management, compliance and corporate sustainability goals.
Caroline Benson, Co-Founder, says, “We’re delighted with our ‘gold’ rating, a big advancement from last year’s ‘silver’, that showcases our dedication to continuous improvement across all our ESG practices.”
Mathew Cutts adds, “This achievement reinforces our pledge to uphold and exceed the highest standards in sustainability across our operations and value chain.”
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients’ lives to build trust and improve outcomes.
Cuttsy+Cuttsy’s upcoming report, ‘The site factor: Where protocol meets practice in clinical trials’, delves into the critical role of site staff in clinical research, offering insights into their daily challenges,…
Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.
Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.
